BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 26700806)

  • 1. Targeting PTPRK-RSPO3 colon tumours promotes differentiation and loss of stem-cell function.
    Storm EE; Durinck S; de Sousa e Melo F; Tremayne J; Kljavin N; Tan C; Ye X; Chiu C; Pham T; Hongo JA; Bainbridge T; Firestein R; Blackwood E; Metcalfe C; Stawiski EW; Yauch RL; Wu Y; de Sauvage FJ
    Nature; 2016 Jan; 529(7584):97-100. PubMed ID: 26700806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RSPO3 expands intestinal stem cell and niche compartments and drives tumorigenesis.
    Hilkens J; Timmer NC; Boer M; Ikink GJ; Schewe M; Sacchetti A; Koppens MAJ; Song JY; Bakker ERM
    Gut; 2017 Jun; 66(6):1095-1105. PubMed ID: 27511199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. R-Spondin chromosome rearrangements drive Wnt-dependent tumour initiation and maintenance in the intestine.
    Han T; Schatoff EM; Murphy C; Zafra MP; Wilkinson JE; Elemento O; Dow LE
    Nat Commun; 2017 Jul; 8():15945. PubMed ID: 28695896
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Greicius G; Kabiri Z; Sigmundsson K; Liang C; Bunte R; Singh MK; Virshup DM
    Proc Natl Acad Sci U S A; 2018 Apr; 115(14):E3173-E3181. PubMed ID: 29559533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive characterization of RSPO fusions in colorectal traditional serrated adenomas.
    Sekine S; Ogawa R; Hashimoto T; Motohiro K; Yoshida H; Taniguchi H; Saito Y; Yasuhiro O; Ochiai A; Hiraoka N
    Histopathology; 2017 Oct; 71(4):601-609. PubMed ID: 28543708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aberrant RSPO3-LGR4 signaling in Keap1-deficient lung adenocarcinomas promotes tumor aggressiveness.
    Gong X; Yi J; Carmon KS; Crumbley CA; Xiong W; Thomas A; Fan X; Guo S; An Z; Chang JT; Liu QJ
    Oncogene; 2015 Sep; 34(36):4692-701. PubMed ID: 25531322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of cell signalings and therapeutic targets in PTPRK-RSPO3 fusion-positive colorectal cancer.
    Jeong JH; Yun JW; Kim HY; Heo CY; Lee S
    PLoS One; 2022; 17(9):e0274555. PubMed ID: 36129915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RSPO3 antagonism inhibits growth and tumorigenicity in colorectal tumors harboring common Wnt pathway mutations.
    Fischer MM; Yeung VP; Cattaruzza F; Hussein R; Yen WC; Murriel C; Evans JW; O'Young G; Brunner AL; Wang M; Cain J; Cancilla B; Kapoun A; Hoey T
    Sci Rep; 2017 Nov; 7(1):15270. PubMed ID: 29127379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. OLFM4 is a robust marker for stem cells in human intestine and marks a subset of colorectal cancer cells.
    van der Flier LG; Haegebarth A; Stange DE; van de Wetering M; Clevers H
    Gastroenterology; 2009 Jul; 137(1):15-7. PubMed ID: 19450592
    [No Abstract]   [Full Text] [Related]  

  • 10. Dual-Blocking of PI3K and mTOR Improves Chemotherapeutic Effects on SW620 Human Colorectal Cancer Stem Cells by Inducing Differentiation.
    Kim MJ; Koo JE; Han GY; Kim B; Lee YS; Ahn C; Kim CW
    J Korean Med Sci; 2016 Mar; 31(3):360-70. PubMed ID: 26955235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A distinct role for Lgr5
    de Sousa e Melo F; Kurtova AV; Harnoss JM; Kljavin N; Hoeck JD; Hung J; Anderson JE; Storm EE; Modrusan Z; Koeppen H; Dijkgraaf GJ; Piskol R; de Sauvage FJ
    Nature; 2017 Mar; 543(7647):676-680. PubMed ID: 28358093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pien Tze Huang inhibits the proliferation, and induces the apoptosis and differentiation of colorectal cancer stem cells via suppression of the Notch1 pathway.
    Qi F; Wei L; Shen A; Chen Y; Lin J; Chu J; Cai Q; Pan J; Peng J
    Oncol Rep; 2016 Jan; 35(1):511-7. PubMed ID: 26530025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of AXIN1 drives acquired resistance to WNT pathway blockade in colorectal cancer cells carrying RSPO3 fusions.
    Picco G; Petti C; Centonze A; Torchiaro E; Crisafulli G; Novara L; Acquaviva A; Bardelli A; Medico E
    EMBO Mol Med; 2017 Mar; 9(3):293-303. PubMed ID: 28100566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The genomic landscape of response to EGFR blockade in colorectal cancer.
    Bertotti A; Papp E; Jones S; Adleff V; Anagnostou V; Lupo B; Sausen M; Phallen J; Hruban CA; Tokheim C; Niknafs N; Nesselbush M; Lytle K; Sassi F; Cottino F; Migliardi G; Zanella ER; Ribero D; Russolillo N; Mellano A; Muratore A; Paraluppi G; Salizzoni M; Marsoni S; Kragh M; Lantto J; Cassingena A; Li QK; Karchin R; Scharpf R; Sartore-Bianchi A; Siena S; Diaz LA; Trusolino L; Velculescu VE
    Nature; 2015 Oct; 526(7572):263-7. PubMed ID: 26416732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effectiveness of an anti-human IL-6 receptor monoclonal antibody combined with chemotherapy to target colon cancer stem-like cells.
    Ying J; Tsujii M; Kondo J; Hayashi Y; Kato M; Akasaka T; Inoue T; Shiraishi E; Inoue T; Hiyama S; Tsujii Y; Maekawa A; Kawai S; Fujinaga T; Araki M; Shinzaki S; Watabe K; Nishida T; Iijima H; Takehara T
    Int J Oncol; 2015 Apr; 46(4):1551-9. PubMed ID: 25625841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colorectal cancer defeating? Challenge accepted!
    Di Franco S; Todaro M; Dieli F; Stassi G
    Mol Aspects Med; 2014 Oct; 39():61-81. PubMed ID: 23927966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activin pathway enhances colorectal cancer stem cell self-renew and tumor progression.
    Liu R; Wang JH; Xu C; Sun B; Kang SO
    Biochem Biophys Res Commun; 2016 Oct; 479(4):715-720. PubMed ID: 27693580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
    Wang D; Fu L; Sun H; Guo L; DuBois RN
    Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. R-spondin-3 promotes proliferation and invasion of breast cancer cells independently of Wnt signaling.
    Ter Steege EJ; Doornbos LW; Haughton PD; van Diest PJ; Hilkens J; Derksen PWB; Bakker ERM
    Cancer Lett; 2023 Aug; 568():216301. PubMed ID: 37406727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting cancer stem cells as therapeutic approach in the treatment of colorectal cancer.
    Parizadeh SM; Jafarzadeh-Esfehani R; Hassanian SM; Parizadeh SMR; Vojdani S; Ghandehari M; Ghazaghi A; Khazaei M; Shahidsales S; Rezayi M; Asgharzadeh F; Ghayour-Mobarhan M; Ferns GA; Avan A
    Int J Biochem Cell Biol; 2019 May; 110():75-83. PubMed ID: 30818083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.